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Introduction
•Massive bone defects is an actual real dilemma for 
reconstructive surgery to the locomotor system.
• The vascularized bone allograft would be a 
successful alternative, with his osteoplastic 
properties of the vascularized autograft and the 
orthotopic characteristics of the allogenic bone.
•Decellularization of organs, including bone, gives 
an acellular biological graft, which keeps their 
extracellular 3D structure.
Objective of the study:
To extract the cellular component from the 
vascularized bone allograft by the combined 
method, according to the algorithm, without 
injuring the extracellular structure and 
matrix.
Material and methods
The study was performing on New 
Zealand White Rabbit. The femur 
was taken with the internal iliac 
artery(I), located between the 
upper part of the great trochanter 
and the distal 1/3 of the femoral 
shaft, respecting the vascular 
continuity.  The grafts were stored 
at -84.1C for 14 days, subsequently 
disengaged by the gradual method. 
The graft was examined 
histologically (A. internal iliac art. 
B. proximal femur)
Results
Conclusions: The combined process of decellularizing of vascularized bone tissue can generate bone grafts devoid of immunological agents.
The decellularized of vessels need additional studies to evaluate the processes for keep its resistance, an imperative factor in subsequent grafting.
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The graft was connected to the 
closed-circuit peristaltic 
pump (II).
After that was processed, gradually, 
with a series of solutions (during 7 
days):
1. sol. NaCl 0,9%-100ml+sol. 
Heparin 500Me/ml-5 ml
2. 0,1g EDTA + sol. PBS 100ml
3. 0,1g EDTA + 150 ml sol. TRIS 
tampon 10 millimolar
4. 0,5g SDS + 100ml sol. TRIS 
tampon 10 millimolar
5. 1ml sol. TRITON-X 100 +
100ml ml sol. TRIS tampon 10 
millimolar
1. 1mg ARNaze + 100ml dist. 
Water
2. 0,153 ml  sol. Penicillin-
Streptomycin (10,000un.-





1. The macroscopic study
2. The microscopic study
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